Results
143
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
143 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
TRAN A | SEK 1.80 | -0.8% | -26.2% | SEK 178.5m | n/a | PE5x | n/a | 23.3% | Diversified Financials | ||
BRE2 New | SEK 2.03 | -1.9% | 14.4% | SEK 1.9b | SEK 2.40 | PE17.7x | E11.8% | 4.9% | Telecom | ||
ANGL | SEK 4.40 | -5.4% | 16.2% | SEK 329.9m | SEK 7.67 | PE11.8x | E26.8% | 0% | Consumer Services | ||
KONT | SEK 2.48 | 0% | 6.0% | SEK 79.5m | SEK 5.20 | PE102.5x | E82.0% | n/a | Healthcare | ||
SPAGO | SEK 0.23 | -10.9% | -24.3% | SEK 79.4m | SEK 0.80 | PS11.5x | E123.4% | n/a | Pharmaceuticals & Biotech | ||
NEWBRY | SEK 3.42 | -2.8% | -26.0% | SEK 83.0m | SEK 8.00 | PS2.6x | E146.2% | n/a | Pharmaceuticals & Biotech | ||
NITRO | SEK 2.94 | 15.7% | -40.5% | SEK 73.3m | SEK 5.01 | PE7.7x | E53.1% | n/a | Media | ||
ACE | SEK 3.04 | 5.0% | -67.2% | SEK 291.7m | SEK 8.25 | PB3.7x | E59.8% | n/a | Pharmaceuticals & Biotech | ||
FREEM | SEK 0.78 | -14.3% | -87.5% | SEK 53.6m | SEK 4.23 | PS1x | E54.8% | n/a | Capital Goods | ||
LPGO | SEK 0.14 | -20.6% | -69.0% | SEK 20.3m | SEK 0.90 | PS2.3x | E139.5% | n/a | Pharmaceuticals & Biotech | ||
ENRO | SEK 0.48 | -2.8% | -21.4% | SEK 352.4m | n/a | PE7.2x | n/a | 8.3% | Media | ||
KAN | SEK 1.07 | 3.3% | -74.3% | SEK 129.7m | SEK 3.10 | PB1.8x | E48.3% | n/a | Pharmaceuticals & Biotech | ||
ICO | SEK 4.32 | -2.0% | -52.9% | SEK 91.7m | SEK 16.75 | PS3.7x | S68.6% | n/a | Healthcare | ||
KLAR | SEK 1.38 | 39.4% | 187.5% | SEK 199.8m | SEK 1.20 | PB15.5x | E93.9% | n/a | Pharmaceuticals & Biotech | ||
SCIB | SEK 0.38 | -10.0% | -41.0% | SEK 82.5m | SEK 1.60 | PS3.1x | E87.7% | n/a | Healthcare | ||
META | SEK 0.086 | -6.0% | -74.0% | SEK 59.0m | SEK 0.12 | PS2.4x | E43.0% | n/a | Capital Goods | ||
FRILAN | SEK 4.92 | 5.6% | 31.2% | SEK 142.9m | n/a | PE12.5x | n/a | 2.0% | Diversified Financials | ||
ELIC | SEK 2.90 | -15.7% | 64.3% | SEK 101.8m | SEK 4.20 | PS14.3x | S119.9% | n/a | Pharmaceuticals & Biotech | ||
NBZ | SEK 0.23 | 15.0% | -34.3% | SEK 56.2m | SEK 0.75 | PS0.3x | S43.2% | n/a | Consumer Durables | ||
ACCON | SEK 4.62 | 1.8% | -47.4% | SEK 287.2m | SEK 8.00 | PS5.6x | E80.8% | n/a | Tech | ||
HIFA B | SEK 3.38 | 4.3% | 33.1% | SEK 205.6m | n/a | PE10.1x | n/a | 0% | Commercial Services | ||
AROC | SEK 0.55 | -2.7% | 31.0% | SEK 126.7m | SEK 0.90 | PS2.5x | E25.6% | n/a | Pharmaceuticals & Biotech | ||
SUSG | SEK 1.06 | 6.0% | 34.2% | SEK 173.8m | n/a | PE35.2x | n/a | n/a | Tech | ||
CLS B | SEK 3.74 | -5.6% | -81.0% | SEK 75.4m | SEK 14.00 | PS4x | E63.8% | n/a | Healthcare |